Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HLA-B associated transcript 1 pseudogene (ENSG00000254406) is a non-protein-coding pseudogene found in the human genome, located in the major histocompatibility complex (MHC) region. Pseudogenes such as this one are remnants of former genes that have lost their ability to encode functional proteins, often due to mutations or insertions that introduce stop codons or disrupt splicing[1][2][7]. Although some pseudogenes may produce regulatory non-coding RNAs, there is no published evidence indicating that this specific pseudogene is functional, participates in any signaling, or is implicated in human disease pathways. It is not considered a therapeutic target, drug target, or molecular biomarker. Based on current knowledge, no additional information is available regarding interacting molecules, alternate names, or specific pathological relevance for this pseudogene. Its inclusion in databases reflects ongoing cataloging of genomic features, but does not suggest functional significance or druggability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HLA-B associated transcript 1 pseudogene.